|Bid||0.6000 x 0|
|Ask||0.6300 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (5Y Monthly)||2.06|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BURLINGTON, Ontario, July 22, 2021--Rapid Dose Therapeutics Announces the Appointment of Advisory Board
BURLINGTON, Ontario, July 20, 2021--Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE) and McMaster University ("McMaster") are pleased to provide the following update regarding the collaborative research into an orally delivered vaccine candidate for COVID-19, following the announcement made on June 23, 2021.
BURLINGTON, Ontario, July 13, 2021--Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE) is pleased to announce that they have entered into a Master Distribution Agreement with Namaste Technologies Inc. (TSXV: N), (FRANKFURT: M5BQ), (OTCMKTS: NXTTF) subsidiary CannMart Inc. for the exclusive sales and distribution of RDT-branded cannabis products into retail locations across Canada.